Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization.

He, Chengjian; Ge, Naijian; Wang, Xiangdong; Li, Hai; Chen, Shiguang; Yang, Yefa

He, Chengjian; Ge, Naijian; Wang, Xiangdong; Li, Hai; Chen, Shiguang; Yang, Yefa.

Afiliación

He C; Mini-Invasive Intervention Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/Navy Medical University, Shanghai, China.
Ge N; Mini-Invasive Intervention Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/Navy Medical University, Shanghai, China.
Wang X; Mini-Invasive Intervention Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/Navy Medical University, Shanghai, China.
Li H; Mini-Invasive Intervention Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/Navy Medical University, Shanghai, China.
Chen S; Department of Interventional Oncology, Fujian Medical University Cancer Hospital, Fuzhou, China.
Yang Y; Mini-Invasive Intervention Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/Navy Medical University, Shanghai, China.

Front Oncol ; 12: 923566, 2022.

Article en En | MEDLINE | ID: mdl-35814420

Palabras clave

conversion therapy; hepatocellular carcinoma (HCC); initial unresectable; portal vein embolization (PVE); transcatheter arterial chemoembolization (TACE); tyrosine kinase inhibitors (TKIs)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google